Researchers from the California company Vave Health have created an ultrasound machine that weighs only 340 grams.
The device connects to a smartphone for data transmission and processing.
Medical ultrasound imaging systems are usually quite large and bulky, but the new Vave probe can be carried in your pocket and connected to a smartphone.
The device is the brainchild of Vave Health CEO Amin Nicosade. The result of his research on the miniaturization of systems that were part of his doctoral dissertation at Stanford was the result of his research.
The 340-gram device consists of a piezoelectric transducer, a lithium-magnesium body that promotes heat dissipation, and a silicone gripper. It is reported that one four-hour charge of its removable lithium-ion battery will suffice for more than an hour of continuous scanning.
Vave also has a water resistance of IP67 (immersed to a depth of 1 meter for half an hour). Users can choose between four imaging settings heart, lungs, abdomen, and obstetrics-gynecology, and they can also manually control settings such as gain, depth, and focus.
Images are viewed in real-time using an application on a smartphone or tablet, iOS, or Android with a Wi-Fi connection. These frames can be saved on both a mobile device and a cloud server.
Vave is available for rent on a subscription fee of 99 per month, which includes replacing the updated probe once every two years.
Earlier, NV wrote that a graduate student in bioengineering, Maha Alafeef, has developed a rapid hypersensitivity test for coronavirus using a paper electrochemical sensor.
"We are now experiencing a life-changing event. We are responding to this global need by taking a holistic approach, developing interdisciplinary tools for the early detection, diagnosis, and treatment of SARS-CoV-2," said Alafeef.
Researchers have recently made big progress in developing biosensors for healthcare equipment with two-dimensional nanomaterials, such as graphene, for detecting disease. Graphene-based biosensors are extremely advantageous due to their sensitivity, fast detection, and low production cost.
An electrochemical biosensor based on graphene with an electrical readout has been developed for detecting the presence of SARS-CoV-2 genetic material selectively.